Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods, BMC Biotechnol, vol.8, p.69, 2008. ,
Serum MicroRNA-21 as marker for necroinflammation in Hepatitis C patients with and without hepatocellular carcinoma, PLoS One, vol.6, 2011. ,
, Nat. Methods, vol.10, 2013.
Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours, Cell. Oncol. (Dordr.), vol.35, pp.301-308, 2012. ,
MicroRNAs in body fluidsdthe mix of hormones and biomarkers, Nat. Rev. Clin. Oncol, vol.8, pp.467-477, 2011. ,
Causes and consequences of microRNA dysregulation in cancer, Nat. Rev. Genet, vol.10, 2009. ,
Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer, World J. Gastrointest. Oncol, vol.6, 2014. ,
Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle, Mol. Oncol, vol.7, 2013. ,
The Vienna RNA websuite, Nucleic Acids Res, vol.36, 2008. ,
Regulation of microRNA biogenesis, Nat. Rev. Mol. Cell Biol, vol.15, 2014. ,
The validity of circulating microRNAs in oncology: five years of challenges and contradictions, Mol. Oncol, vol.8, 2014. ,
Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells, Mol. Cell, vol.46, 2012. ,
Haemolysis during sample preparation alters microRNA content of plasma, PLoS One, vol.6, 2011. ,
Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study, BMJ Open, vol.2, 2012. ,
Analysis of circulating microRNA: preanalytical and analytical challenges, Clin. Chem, vol.57, 2011. ,
Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients, Br. J. Cancer, vol.113, 2015. ,
Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study, Nat. Methods, vol.11, 2014. ,
Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. U. S. A, vol.105, 2008. ,
Methodological challenges in utilizing miRNAs as circulating biomarkers, J. Cell. Mol. Med, vol.18, 2014. ,
Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells, BMC Genomics, vol.15, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02191582
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial, Breast Cancer Res. Treat, vol.147, pp.61-68, 2014. ,
,
Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs, BioTechniques, vol.48, 2010. ,
Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies, Cancer Prev. Res. (Phila.), vol.5, pp.492-497, 2012. ,
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform, Nat. Rev. Clin. Oncol, vol.112, pp.1333-1342, 2009. ,
Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients, Oncotarget, vol.6, 2015. ,
Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs, Sci. Rep, vol.5, p.9430, 2015. ,
Circulating microRNA biomarker studies: pitfalls and potential solutions, Clin. Chem, vol.61, 2015. ,
Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated metaanalysis based on 36 studies, Tumour Biol. e J. Int. Soc. Oncodevelopmental Biol. Med, vol.36, 2015. ,